2024
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study
Vaughn J, Ramdhanny A, Munir M, Rimmalapudi S, Epperla N. A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study. Blood Cancer Journal 2024, 14: 212. PMID: 39609401, PMCID: PMC11604794, DOI: 10.1038/s41408-024-01194-5.Peer-Reviewed Original ResearchConceptsIndolent non-Hodgkin lymphomaLymphoma-specific survivalDe novo DLBCLOverall survivalIndolent lymphomaT-FLHistological transformationRelative survivalDe novo diffuse large B-cell lymphomaIndolent non-Hodgkin's lymphoma subtypesDiffuse large B-cell lymphomaReceipt of prior chemotherapyAssociated with inferior survivalLarge B-cell lymphomaMedian follow-up timeStudy of adult patientsLymphoplasmacytic lymphoma/Waldenstrom macroglobulinemiaTransformed indolent lymphomaMarginal zone lymphomaNon-Hodgkin's lymphomaB-cell lymphomaTransformed follicular lymphomaIncidence of HTPopulation-based cohort studyPopulation-based study
2022
CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
Vaughn J, Brown S, Papadopoulos E, Jakubowski A, Tamari R, Giralt S, Ponce D, Cho C, Perales M, Shaffer B, Gyurkocza B. CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era. Bone Marrow Transplantation 2022, 57: 1740-1742. PMID: 36076011, DOI: 10.1038/s41409-022-01783-7.Peer-Reviewed Original ResearchRacial differences in the survival of mantle cell lymphoma patients in the United States
Vaughn J, Gundepalli S, Epperla N. Racial differences in the survival of mantle cell lymphoma patients in the United States. Hematological Oncology 2022, 40: 479-481. PMID: 35245968, DOI: 10.1002/hon.2984.Peer-Reviewed Original Research
2021
Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
Vaughn J, Soroka O, Epperla N, Safford M, Pinheiro L. Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States. Cancer Medicine 2021, 10: 7330-7338. PMID: 34469069, PMCID: PMC8525101, DOI: 10.1002/cam4.4249.Peer-Reviewed Original ResearchConceptsAutologous hematopoietic cell transplantationNon-Hispanic black patientsHematopoietic cell transplantationNon-Hispanic white patientsDisease-specific factorsBlack patientsWhite patientsLymphoma patientsNon-Hispanic black race/ethnicityEthnic disparitiesPopulation-based cohort studyBlack race/ethnicityCox proportional hazards modelEnd Results (SEER) dataNon-Hodgkin lymphomaPopulation-based dataProportional hazards modelEthnic differencesReceipt of transplantRace/ethnicityCohort studyPrimary outcomeAutologous transplantCell transplantationAutologous transplantationRacial disparities in the survival of patients with indolent non‐Hodgkin lymphomas in the United States
Vaughn J, Spies D, Xavier A, Epperla N. Racial disparities in the survival of patients with indolent non‐Hodgkin lymphomas in the United States. American Journal Of Hematology 2021, 96: 816-822. PMID: 33864695, DOI: 10.1002/ajh.26198.Peer-Reviewed Original ResearchConceptsIndolent non-Hodgkin lymphomaSurvival of patientsHighest excess mortality ratesYoung black patientsBlack patientsNon-Hodgkin lymphomaExcess mortality ratesRelative survivalWhite patientsRacial disparitiesMortality rateExcess deathsLymphoplasmacytic lymphoma/Waldenström macroglobulinemiaFlexible parametric survival modelsAmerican Indians/Alaska NativesMarginal zone lymphomaAsian/Pacific IslandersSignificant racial differencesPaucity of dataAdult patientsDisease histologyPrimary outcomeParametric survival modelsMultivariable analysisWaldenström's macroglobulinemiaSurvival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017)
Vaughn J, Pinheiro L, Olszewski A, Epperla N. Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017). American Journal Of Hematology 2021, 96: e123-e126. PMID: 33476433, DOI: 10.1002/ajh.26103.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesConfounding Factors, EpidemiologicFemaleHumansKaplan-Meier EstimateLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedMortalityPrognosisRituximabSEER ProgramSocial Determinants of HealthUnited StatesYoung Adult
2010
Contribution of Amino Acid Region 659−663 of Factor Va Heavy Chain to the Activity of Factor Xa within Prothrombinase,
Hirbawi J, Vaughn J, Bukys M, Vos H, Kalafatis M. Contribution of Amino Acid Region 659−663 of Factor Va Heavy Chain to the Activity of Factor Xa within Prothrombinase,. Biochemistry 2010, 49: 8520-8534. PMID: 20722419, PMCID: PMC2946813, DOI: 10.1021/bi101097t.Peer-Reviewed Original Research